- 
				
A novel haplotype in LRRK2 is associated with risk for multiple system atrophy in the Korean population
 - 
				
A novel homozygous DJ1 mutation causes parkinsonism and ALS in a Turkish family
 - 
				
A novel interdisciplinary palliative care clinic for advanced Parkinson’s disease and Parkinsonian syndromes
 - 
				
A novel phenotype associated with GRN mutations: Spastic ataxia
 - 
				
A novel phenotype of amyloid precursor protein (APP) mutation presenting with dementia, and symptoms of both progressive supranulcear palsy (PSP) and multisystem atrophy (MSA)
 - 
				
A novel single molecule imaging approach to detect individual protein oligomers in CSF from patients with Parkinson’s disease (PD)
 - 
				
A peripheral pathway to restless legs syndrome? Clues from familial amyloid polyneuropathy
 - 
				
A phase 3, placebo-controlled study with an open-label extension: Sustained incobotulinumtoxinA efficacy in upper-limb post-stroke spasticity over 48 weeks
 - 
				
A phase II, pragmatic, randomized clinical trial on a high-intensity exercise and fall prevention boot camp for Parkinson’s disease: Feasibility and safety
 - 
				
A phase II, pragmatic, randomized clinical trial on a high-intensity exercise and fall prevention boot camp for Parkinson’s disease: Signal of efficacy
 
- « Previous Page
 - 1
 - …
 - 5
 - 6
 - 7
 - 8
 - 9
 - …
 - 207
 - Next Page »
 
